Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/27324
Full metadata record
DC FieldValueLanguage
dc.contributor.authorWiendl, H.-
dc.contributor.authorCarraro, M.-
dc.contributor.authorComi, G.-
dc.contributor.authorIzquierdo, G.-
dc.contributor.authorKim, H. J.-
dc.contributor.authorSharrack, B.-
dc.contributor.authorTornatore, C.-
dc.contributor.authorDaizadeh, N.-
dc.contributor.authorMelanson, M.-
dc.contributor.authorJACOBS, Andre-
dc.contributor.authorVAN WIJMEERSCH, Bart-
dc.date.accessioned2018-11-12T14:07:49Z-
dc.date.available2018-11-12T14:07:49Z-
dc.date.issued2018-
dc.identifier.citationEUROPEAN JOURNAL OF NEUROLOGY, 25(S2), p. 539-539-
dc.identifier.issn1351-5101-
dc.identifier.urihttp://hdl.handle.net/1942/27324-
dc.description.sponsorshipSanofi; Bayer HealthCare Pharmaceuticals-
dc.language.isoen-
dc.publisherWILEY-
dc.titleLack of apparent association between lymphocyte repopulation kinetics and autoimmune events in alemtuzumab-treated patients with relapsing-remitting Multiple Sclerosis through 6 years: CARE-MS extension-
dc.typeJournal Contribution-
local.bibliographicCitation.conferencedateJUN 16-19, 2018-
local.bibliographicCitation.conferencename4th Congress of the European-Academy-of-Neurology (EAN)-
local.bibliographicCitation.conferenceplaceLisbon, PORTUGAL-
dc.identifier.epage539-
dc.identifier.issueS2-
dc.identifier.spage539-
dc.identifier.volume25-
local.format.pages1-
local.bibliographicCitation.jcatM-
dc.description.notes[Wiendl, H.] Univ Munster, Munster, Germany. [Carraro, M.] Novant Hlth, Charlotte, NC USA. [Comi, G.] Univ Vita Salute San Raffaele, Milan, Italy. [Izquierdo, G.] Virgen Macarena Univ Hosp, Seville, Spain. [Kim, H. J.] Natl Canc Ctr, Res Inst & Hosp, Goyang, South Korea. [Sharrack, B.] Sheffield Teaching Hosp NHS Fdn Trust, Sheffield, S Yorkshire, England. [Tornatore, C.] Georgetown Univ, Med Ctr, Washington, DC 20007 USA. [Daizadeh, N.; Melanson, M.; Jacobs, A.] Sanofi, Cambridge, MA USA. [van Wijmeersch, B.] Hasselt Univ, BIOMED, Rehabil & MS Ctr Overpelt, Hasselt, Belgium.-
local.publisher.placeHOBOKEN-
local.type.refereedRefereed-
local.type.specifiedMeeting Abstract-
dc.identifier.isi000435272002429-
item.fulltextNo Fulltext-
item.accessRightsClosed Access-
item.contributorComi, G.-
item.contributorVAN WIJMEERSCH, Bart-
item.contributorSharrack, B.-
item.contributorCarraro, M.-
item.contributorTornatore, C.-
item.contributorKim, H. J.-
item.contributorMelanson, M.-
item.contributorJACOBS, Andre-
item.contributorWiendl, H.-
item.contributorIzquierdo, G.-
item.contributorDaizadeh, N.-
item.fullcitationWiendl, H.; Carraro, M.; Comi, G.; Izquierdo, G.; Kim, H. J.; Sharrack, B.; Tornatore, C.; Daizadeh, N.; Melanson, M.; JACOBS, Andre & VAN WIJMEERSCH, Bart (2018) Lack of apparent association between lymphocyte repopulation kinetics and autoimmune events in alemtuzumab-treated patients with relapsing-remitting Multiple Sclerosis through 6 years: CARE-MS extension. In: EUROPEAN JOURNAL OF NEUROLOGY, 25(S2), p. 539-539.-
crisitem.journal.issn1351-5101-
crisitem.journal.eissn1468-1331-
Appears in Collections:Research publications
Show simple item record

Page view(s)

14
checked on Jul 3, 2022

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.